Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, December 10, 2009, 2:13PM ET - U.S. Markets close in 1 hour and 47 minutes. Dow Up 0.70% Nasdaq Up 0.54%
Chembio Diagnostics, Inc. (CEMI.OB)At 1:40PM ET: 0.275  Down 0.005 (1.79%)  
MORE ON CEMI.OB
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Chembio Diagnostics, Inc.
3661 Horseblock Road
Medford, NY 11763
United States - Map
Phone: 631-924-1135
Web Site: http://www.chembio.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Diagnostic Substances
Full Time Employees:110

BUSINESS SUMMARY 
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and markets rapid diagnostic tests for the detection of HIV antibodies in whole blood, serum, and plasma samples. Its products utilize lateral flow technology and Dual Path Platform (DPP). The company’s rapid tests include SURE CHECK HIV 1/2, HIV 1/2 STAT-PAK, HIV 1/2 STAT-PAK Dipstick, and DPP HIV 1/2. It also manufactures rapid tests for Chagas disease, as well as a line of rapid tests for the detection of tuberculosis in humans and certain animal species. Chembio Diagnostics sells its tests to medical laboratories and hospitals, governmental and public health entities, nongovernmental organizations, medical professionals, and retail establishments worldwide. It has collaboration, research, development, licensing, or marketing agreements with United States Centers for Disease Control; Bio-Rad Laboratories N.A.; Bio-Manguinhos division of the Oswald Cruz Foundation; and Inverness Medical Innovations, Inc. The company was founded in 1985 and is based in Medford, New York.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Chembio Diagnostics, Inc.


    CORPORATE GOVERNANCE 
    Chembio Diagnostics, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 74.3% of CGQ Universe companies and 50.4% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Lawrence A. Siebert , 52
    Exec. Chairman, Chief Exec. Officer, Pres, Chairman of Chembio Diagnostic Systems Inc, Chief Exec. Officer of Chembio Diagnostics Inc and Pres of Chembio Diagnostic Systems Inc
    $ 291.00KN/A
    Mr. Richard J. Larkin , 53
    Chief Financial Officer, Principal Accounting Officer, Sec. and Chief Financial Officer of Chembio Diagnostic Systems Inc
    $ 178.00KN/A
    Mr. Richard Bruce , 55
    VP of Operations
    $ 163.00KN/A
    Mr. Javan Esfandiari , 43
    Exec. VP of R&D
    $ 231.00KN/A
    Mr. Tom Ippolito , 46
    VP of Regulatory Affairs, Quality Assurance & Quality Control
    $ 185.00KN/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis